Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery

Clinical trial NCT06168799 · COMPLETED

Trial details

NCT number: NCT06168799
Sponsor: AM-Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Open Heart Surgery

Start date: 2023-12-19
Primary completion: 2025-10-05
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.